**Core Tip:** The aim of this study was to elucidate the endoscopic characteristics of small intestinal malignant tumors. Balloon-assisted enteroscopy procedures at our institution were enrolled in the analysis. Malignant tumors were classified into three groups, Group 1: epithelial tumors; Group 2: small intestinal malignant lymphoma; and Group 3, small intestinal gastrointestinal stromal tumors. We collected data from patients' medical records to determine the endoscopic characteristics for each group. Group 1 and Group 2 were observed as solitary tumors. Enlarged white villi inside and/or surrounding the tumor were seen in 12.5%, 54.5%, and 0% in Group 1, 2, and 3, respectively (*P* \<0.001).

INTRODUCTION
============

The small intestine is a long luminal organ that constitutes 75% of the length of gas-trointestinal tract and 90% of its mucosal surface area. Small intestinal cancer is relatively rare, accounting for less than 5% of gastrointestinal cancers\[[@B1]\] and with an incidence of 6.8 cases per million\[[@B2]\]. The gastrointestinal tract is a major organ affected by extranodal malignant lymphoma, accounting for 30%--40% of all extranodal lymphomas and 5%--20% of all non-Hodgkin lymphomas\[[@B3]\]. The most frequent primary gastrointestinal site of malignant lymphoma is the stomach (60%--70%), followed by the small intestine (20%--30%)\[[@B4]\]. Until the development of balloon-assisted enteroscopy (BAE) and video capsule endoscopy, small intestinal malignant tumors could not be observed endoscopically. Moreover, BAE enables direct observation of these small intestinal lesions, and also permits biopsy and endoscopic therapy, such as stent placement and endoscopic tattooing for subsequent surgical therapy\[[@B5],[@B6]\]. A previous study reported the incidence of small intestinal tumors detected by BAE\[[@B6],[@B7]\]; however, the endoscopic characteristics of small intestinal tumors have been reported only in a limited number of case reports\[[@B8]-[@B10]\], and the details of these characteristics are still unknown.

The aim of this study was to investigate the endoscopic characteristics of small intestinal malignant tumors observed by BAE.

MATERIALS AND METHODS
=====================

This study was a retrospective medical record analysis and was approved by the ethics committee of Keio University Hospital (approval number, 20160431). Data was collected from patients' medical records, and the endoscopy findings were collected using an endoscopy reporting system (Solemio ENDO^®^, Olympus, Tokyo, Japan). Patients who underwent BAE (EN450/T5 or EN450/P5; Fujifilm, Tokyo, Japan or SIF-Q260; Olympus, Tokyo, Japan) between March 2005 and February 2017 in Keio University Hospital were screened. Of the 1328 procedures, 44 small intestinal malignant tumors were seen endoscopically, and data for these tumors were included in the analysis. Benign small intestinal polyp and polyposis syndrome such as Peutz--Jeghers syndrome and familial adenomatous were excluded from the analysis. The included small intestinal malignant tumors were classified into three groups: Group 1: epithelial tumors including primary small intestinal cancer (ade-no-carcinoma), metastatic small intestinal cancer (adenocarcinoma), and direct small intestinal invasion by adjacent organ cancer (adenocarcinoma); Group 2: small intestinal malignant lymphoma; and Group 3: small intestinal gastrointestinal stromal tumors (GIST). Patients' clinical background parameters included age, symptom, and laboratory data. To define the endoscopic characteristics for each group, endoscopic data such as tumor location, solitary or multiple lesions, type or form, presence of stenosis, presence of bleeding, and presence of white villi were systematically collected from patients' medical charts and the endoscopy reporting system. Solitary and multiple lesions were confirmed by computed tomography and/or barium swallow. Stricture was defined as a stenosis through which we could not pass an enteroscope (EN450/T5 or SIF-Q260). Bleeding was defined as spontaneous bleeding before passing the enteroscope. We also focused on the endoscopic findings of white villi in malignant lymphoma. To determine the morphological and pathological characteristics of white villi in malignant lymphoma, we compared the pathological findings and endoscopic findings from each biopsy site.

Statistical analysis
--------------------

Statistical analyses were performed using the Fisher's exact test for percentages and one way ANOVA to assess differences in parameters showing a normal distribution. Non- normally distributed data were analyzed using the Kruskal--Wallis test. *P*-values \< 0.05 were considered significant, and SPSS version 22 software (SPSS Inc., Tokyo, Japan) was used for all statistical analyses.

RESULTS
=======

A flow diagram of patient enrollment is shown in Figure [1](#F1){ref-type="fig"}. In total, 1328 BAE procedures were performed from March 2005 to February 2017. Of these 1328 procedures, the number of patients in each group was 16 (Group 1), 22 (Group 2), and 6 (Group 3) (Figure [1](#F1){ref-type="fig"}). Table [1](#T1){ref-type="table"} shows the patients' characteristics. We found no statistically-significant difference in age, symptoms (epigastric pain, melena, weight loss), and blood test results (white blood cell count, hemoglobin, lactate dehydrogenase) between the groups. The endoscopic characteristics of the small intestinal malignant tumors are shown in Table [2](#T2){ref-type="table"} and Figure [2](#F2){ref-type="fig"}. Seventy-five percent of epithelial tumors (Group 1) were located in the upper small intestine (duodenum and jejunum), and approximately 70% of GISTs were located in the jejunum. The percentage of solitary tumors was 100%, 45.5%, and 100% in Group 1, 2, and 3, respectively (*P* \< 0.001). Solitary protruding or mass-type tumors were not seen in malignant lymphoma (Group 2) (*P* \<0.001). Solitary infiltrative ulcerated type tumors were seen only in Group1 (*P* = 0.007) (Figure [2A](#F2){ref-type="fig"}). Multiple lesions with ulcerated surfaces or polyposis were seen only in Group 2, and stenosis was seen more frequently in Group 1, (68.8%, 27.3%, and 0%; Group 1, 2, and 3, respectively; *P* = 0.004). Although the difference was not statistically significant, Group1 tended to have more bleeding compared with Group 2 and 3. Enlarged white villi inside and/or surrounding the tumor were seen in 12.5%, 54.5%, and 0% in Group 1, 2 and 3, respectively (*P* \< 0.001) (Figure [2B](#F2){ref-type="fig"} and C). We further investigated the pathological and morphological features of white villi in Group 2. Adequate biopsy samples were not obtained from four patients; therefore, we excluded data for these patients from the analysis (Table [3](#T3){ref-type="table"}). Of the 22 Group 2 patients, enlarged white villi were seen in 12 patients. At the biopsy sites where most of the white villi were seen, lymphoma cells infiltrated into the villi with an intact epithelium; villi were filled with lymphoma cells (Table [3](#T3){ref-type="table"} and Figure [3](#F3){ref-type="fig"}). When the intact epithelium was ulcerated or lymphoma cells were present in the deep mucosa, white villi could not be seen (Table [3](#T3){ref-type="table"} and Figure [4](#F4){ref-type="fig"}).

###### 

Patients' characteristics

                                   **Group 1** **(epithelial)**   **Group 2** **(malignant lymphoma)**   **Group 3** **(GIST)**   ***P*-value**
  -------------------------------- ------------------------------ -------------------------------------- ------------------------ ---------------
  Age (mean ± SD)                  62.9 ± 13.7                    67.7 ± 7.1                             67.0 ± 11.9              0.47
  Symptom (%)                                                                                                                     
  Epigastric pain                  25.0 (4/16)                    27.3 (6/22)                            0 (0/6)                  0.36
  Melena                           25.0 (4/16)                    13.6 (3/22)                            16.7 (1/6)               0.67
  Weight loss                      6.3 (1/16)                     4.5 (1/22)                             0 (0/16)                 0.82
  Other                            43.8 (7/16)                    54.5 (12/22)                           83.3 (5/6)               N/A
  Blood test results (mean ± SD)                                                                                                  
  WBC (/μL)                        7712.5 ± 3428.1                6536.4 ± 2858.5                        4950.0 ± 1312.6          0.25
  Hb (g/dL)                        10.7 ± 2.7                     11.6 ± 2.1                             12.2 ± 2.4               0.63
  LDH (IU/L)                       201.0 ± 52.1                   189.9 ± 49.1                           175.0 ± 35.8             0.35

N/A: Not applicable: GIST: Gastrointestinal stromal tumor; WBC: White blood cell count; Hb: Hemoglobin; LDH: Lactate dehydrogenase.

![Flow diagram of the patient enrollment. DLBCL: Diffuse large B-cell lymphoma; GIST: Gastrointestinal stromal tumor; MALT: Mucosa-associated lymphoid tissue.](WJGE-11-373-g001){#F1}

###### 

Endoscopic characteristics of the small intestinal malignant tumors

                                         **Group 1 (Epithelial) (%)**   **Group 2 (Malignant lymphoma) (%)**   **Group 3 (GIST) (%)**   ***P*-value**
  -------------------------------------- ------------------------------ -------------------------------------- ------------------------ ---------------
  Tumor location                                                                                                                        
  Duodenum                               43.8 (7/16)                    18.2 (4/22)                            16.7 (1/6)               0.18
  Jejunum                                31.3 (5/16)                    50.0 (11/22)                           66.7 (4/6)               0.28
  Ileum                                  25.0 (4/16)                    45.5 (10/22)                           16.7 (1/6)               0.26
  Solitary lesion                        100.0 (16/16)                  45.5 (10/22)                           100.0 (6/6)              \< 0.001
  Type or form                                                                                                                          
  Solitary                                                                                                                              
  Protruded or mass type                 31.3 (5/16)                    0 (0/22)                               66.7 (4/6)               \< 0.001
  Ulcerated type (with raised margins)   37.5 (6/16)                    40.9 (9/22)                            33.3 (2/6)               0.94
  Infiltrative ulcerated type            31.3 (5/16)                    0 (0/22)                               0 (0/6)                  0.007
  Multiple                                                                                                                              
  Multiple ulcers                        0 (0/16)                       22.7 (5/22)                            0 (0/6)                  0.06
  MLP                                    0 (0/16)                       13.6 (3/22)                            0 (0/6)                  0.20
  Others                                 0 (0/16)                       22.7 (5/22)                            0 (0/6)                  N/A
  Presence of stenosis                   68.8 (11/16)                   27.3 (6/22)                            0 (0/6)                  0.004
  Presence of bleeding                   43.8 (7/16)                    22.7 (5/22)                            16.7 (1/6)               0.178
  White villi                            12.5 (2/16)                    54.5 (12/22)                           0 (0/6)                  \< 0.001

GIST: Gastrointestinal stromal tumor; MLP: Multiple lymphomatous polyposis.

![Endoscopic findings for each small intestinal tumor. A: Representative image of an epithelial tumor (Group 1: primary small intestinal cancer). This tumor was solitary and located in the jejunum. The type was infiltrative ulcerated type. This tumor was also associated with stenosis and bleeding; B and C: Representative images of malignant lymphoma (Group 2: diffuse large B-cell lymphoma). These tumors were multiple and located in the jejunum and ileum and appeared as ulcerated masses with raised margins. These tumors also had white villi (arrows) and were not associated with stenosis or bleeding; D: Representative image of a gastrointestinal stromal tumor (Group 3). This tumor was solitary and located in the jejunum and appeared as a protruded mass. This tumor was not associated with stenosis or bleeding.](WJGE-11-373-g002){#F2}

###### 

Pathological features of the biopsy sites with or without white villi in malignant lymphoma

                                                                       **White villi**   ***P*-value**   
  -------------------------------------------------------------------- ----------------- --------------- ----------
  Lymphoma cells infiltrating the villi with an intact epithelium      91.7% (11/12)     0 % (0/10)      \< 0.001
  Lymphoma cells infiltrating the villi without an intact epithelium   0% (0/12)         50.0% (5/10)    0.293
  Lymphoma cells present in the deep mucosa                            0% (0/12)         20.0% (2/10)    0.195
  Not assessed                                                         8.3% (1/12)       30% (3/10)      N/A

N/A: Not applicable.

![Endoscopic and pathological findings of the white villi. Representative endoscopic and pathological images of the white villi (Follicular lymphoma). A: White light image with indigo carmine staining shows diffuse white villi in the ileum; B, C: Pathological images are showing the lymphoma cells infiltrating the villi with an intact epithelium. Most of the villi are filled with lymphoma cells, which formed lymphoid follicles (B: Hematoxylin and eosin staining, × 10; C: Immunohistochemical staining for bcl-2 was positive, ×10).](WJGE-11-373-g003){#F3}

![Endoscopic and pathological images of malignant lymphoma without white villi appearance. A, B: Representative endoscopic and pathological images of malignant lymphoma without white villi appearance (Follicular lymphoma) \[A: White light image shows enlarged villi with stenosis, without white villi appearance in the ileum (with stenosis); B: Pathological image is showing the lymphoma cells sparsely infiltrating the villi, some lymphoma cells present in the deep mucosa (blue arrow), immunohistochemical staining for bcl-2, ×10\]; C, D: Representative endoscopic and pathological images of malignant lymphoma without white villi appearance (Mantle cell lymphoma) (C: White light image with indigo carmine staining shows multiple polyposis with ulceration, without white villi appearance in the ileum; D: Pathological image is showing the lymphoma cells infiltrating the mucosa without an intact epithelium, immunohistochemical staining for cyclin D1, ×10).](WJGE-11-373-g004){#F4}

DISCUSSION
==========

In the current study, we described the endoscopic characteristics of tumor location and morphology of small intestinal malignant tumors. Small intestinal malignant tumors were classified into three groups, and statistical analyses were performed between the groups. Patients' clinical background parameters including age, symptoms, and laboratory data were not significantly different between the groups. First, we evaluated the endoscopic characteristics of tumor location and the number of tumors. Approximately three quarters of epithelial tumors were found in the duodenum or jejunum, and all were observed as solitary lesions (Table [2](#T2){ref-type="table"}). Previous studies using BAE reported that primary small intestinal adenocarcinoma was located mainly in the duodenum or jejunum with a range of 77.8%--100.0%\[[@B6],[@B7],[@B11]-[@B14]\]. Primary small intestinal adenocarcinoma was reported as a solitary lesion in several studies\[[@B6],[@B7],[@B12]-[@B14]\], which was consistent with our results, whereas metastatic tumors were sometimes observed as multiple lesions\[[@B11],[@B15]\]. In our classification, primary and metastatic tumors were classified into the same groups; however, it might be better to distinguish between metastatic and primary tumors. In the current study, malignant lymphoma lesions were located mainly in the jejunum and ileum, and approximately 60% were multiple lesions (Table [2](#T2){ref-type="table"}), consistent with previous reports\[[@B11]-[@B14],[@B16]\]. GISTs are reported mainly as solitary jejunal tumors\[[@B11]-[@B13],[@B17],[@B18]\]. Nakano et al\[[@B19]\] reported that 76% of patients with GIST had jejunal lesions, and that 3/25 patients had tumors in multiple sites (stomach and jejunum: 1; duodenum and jejunum: 1; and stomach, duodenum, and jejunum: 1). A particular type of GIST that is associated with neurofibromatosis type1 appears as multiple tumors\[[@B20]-[@B22]\]. However, as our results, most GISTs appeared as a solitary jejunal tumor, except for neurofibromatosis type1 associated type\[[@B20]-[@B22]\].

The endoscopic morphology of small intestinal tumors has not been systemically evaluated. In the current study, we evaluated the endoscopic morphology of small intestinal tumors. Epithelial tumors appeared as protruded or mass type, ulcerated type, or infiltrative ulcerated type, and 68.8% (11/16) were associated with stenosis. The infiltrative ulcerated type was typically recognized in epithelial tumors (Figure [2A](#F2){ref-type="fig"}). Malignant lymphoma appeared mainly as multiple lesions such as multiple ulcers or multiple lymphomatous polyposis (MLP), and stenosis was detected in 6/22 patients (27.3%). GIST was observed as the protruded or mass type \[66.7% (4/6)\], or the ulcerated type \[33.3 % (2/6)\] without stenosis. Chung et al\[[@B7]\] and Imaoka et al\[[@B12]\] reported that most small bowel adenocarcinomas appeared as the ulcerative form. Imaoka et al\[[@B12]\] and Almeida et al\[[@B23]\] reported that most epithelial small bowel tumors were associated with stenosis \[70% (7/10) and 100% (3/3), respectively\], similar to our findings. Previous reports\[[@B12],[@B23],[@B24]\] showed that malignant lymphoma occurred mainly as multiple lesions, such as multiple ulcers or MLP. MLP as multiple white nodules was observed in follicular lymphoma in previous studies\[[@B3],[@B24]-[@B27]\]. Nakano et al\[[@B19]\] reported that the morphology of GISTs was classified into three groups: intraductal, extraductal, and mixed type. Lesions in 21 patients occurred as submucosal tumors and two occurred as diverticular transformation, in the 18 patients with ulceration. We saw no diverticular transformation in our study.

Of 22 patients with malignant lymphoma, enlarged white villi were seen in 12 patients (Table [2](#T2){ref-type="table"}, Figure [3](#F3){ref-type="fig"}). The pathological and morphological features of the white villi biopsy sites showed that the lymphoma cells had infiltrated into the villi with an intact epithelium (Table [3](#T3){ref-type="table"} and Figure [3](#F3){ref-type="fig"}). In the current study, there were two types of malignant lymphoma that did not exhibit white villi. The first type showed the lymphoma cells sparsely infiltrated the villi, some lymphoma cells presented in the deep mucosa (Figure [4A](#F4){ref-type="fig"} and B). The second type showed the lymphoma cells infiltrated the mucosa without an intact epithelium (Figure [4C](#F4){ref-type="fig"} and D). Endoscopic findings of follicular lymphoma were described as "multiple polypoid lesions" and "multiple whitish small polyps" in a previous study\[[@B24]\]. These whitish polypoid lesions were seen as enlarged white villi using magnifying endoscopy\[[@B28]-[@B30]\]. Yamamoto et al\[[@B24]\] reported that each white enlarged villus was an enlarged neoplastic follicle consisting of lymphoma cells in the lamina propria, which was confirmed histologically. Another report showed that enlarged white duodenal villi were caused by infiltration of lymphoma cells into the villi, which formed lymphoid follicles\[[@B29]\]. From the pathological findings of our study, jejunal and/or ileal white villi in malignant lymphoma, even in other than the follicular type, are considered to consist of lymphoma cells in the lamina propria as with duodenal follicular lymphoma. Previous reports describe white villi of duodenal follicular lymphoma using esophagogastroduodenoscopy\[[@B24],[@B28]-[@B30]\]. To our knowledge, ours is the first report of white villi in jejunal and ileal malignant lymphoma observed by BAE.

The endoscopic characteristics of the small intestinal tumors in our study are summarized in Table [4](#T4){ref-type="table"}. Generally, epithelial small intestinal tumors appeared as solitary tumors with stenosis, small intestinal malignant lymphoma tumors as multiple tumors with white villi, and GISTs as solitary protruded lesions.

###### 

Summary of the endoscopic characteristics of the small intestinal tumors

                                **Group 1 (Epithelial)**   **Group 2 (Malignant lymphoma)**   **Group 3 (GIST)**
  ----------------------------- -------------------------- ---------------------------------- --------------------
  Solitary tumor                1                          2                                  1
  Protruded or mass type        2                          3                                  1
  Infiltrative ulcerated type   2                          3                                  3
  Presence of stenosis          1                          2                                  3
  White villi                   3                          2                                  3

1: More likely; 2: Intermediate; 3: Less likely; GIST: Gastrointestinal stromal tumor.

Several limitations of this study should be addressed. First, this was a retrospective study; thus, many confounding factors could affect the results. Second, small intestinal tumors are very rare, and our sample size was relatively small. Future studies require higher numbers of patients to analyze larger datasets. However, there have been few studies to show the differences of endoscopic features among group1, 2 and 3. Furthermore, the importance of "white villi" could be emphasized in our study.

In conclusion, based on endoscopic findings during BAE, we were able to make tentative differential diagnoses of small intestinal malignant tumors.

ARTICLE HIGHLIGHTS
==================

Research background
-------------------

Capsule endoscopy and balloon-assisted enteroscopy (BAE) enable visualization of rare small bowel conditions such as small intestinal malignant tumors.

Research motivation
-------------------

The details of the endoscopic characteristics of small intestinal malignant tumors are still unknown.

Research objectives
-------------------

The aim of this retrospective study was to elucidate the endoscopic characteristics of small intestinal malignant tumors.

Research methods
----------------

This study was a retrospective medical record analysis. From March 2005 to February 2017, 1328 BAE procedures were performed at Keio University Hospital. Of these procedures, malignant tumors were classified into three groups, Group 1: epithelial tumors including primary small intestinal cancer, metastatic small intestinal cancer, and direct small intestinal invasion by an adjacent organ cancer; Group 2: small intestinal malignant lymphoma; and Group 3, small intestinal gastrointestinal stromal tumors. We systematically collected clinical and endoscopic data from patients' medical records to determine the endoscopic characteristics for each group.

Research results
----------------

The number of patients in each group was 16 (Group 1), 22 (Group 2), and 6 (Group 3), and the percentage of solitary tumors was 100%, 45.5%, and 100%, respectively (*P* \< 0.001). Solitary protruding or mass-type tumors were not seen in malignant lymphoma (Group 2) (*P* \< 0.001). Stenosis was seen more often in Group 1, (68.8%, 27.3%, and 0%; Group 1, 2, and 3, respectively; *P* = 0.004). Enlarged white villi inside and/or surrounding the tumor were seen in 12.5%, 54.5%, and 0% in Group 1, 2, and 3, respectively (*P* = 0.001).

Research conclusions
--------------------

The differential diagnosis of small intestinal malignant tumors could be tentatively made based on BAE findings.

Research perspectives
---------------------

Future studies require higher numbers of patients to analyze larger datasets.
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